SAXE JON S

The estimated Net Worth of SAXE JON S is at least $379,102.23 dollars as of 05/24/2022. SAXE JON S is the Director of Durect Corp. SAXE JON S owns over 177,810 shares of Durect Corp stock worth over $70,101.59. SAXE JON S is the Director of PDL BioPharma Inc. SAXE JON S owns over 102,680 shares of PDL BioPharma Inc stock worth over $253,619.60. SAXE JON S is the Director of VistaGen Therapeutics Inc. SAXE JON S owns over 53,251 shares of VistaGen Therapeutics Inc stock worth over $55,381.04.

SAXE JON S mailing address: FIRST HORIZON PHARMACEUTICAL CORP 660 HEMBREE PKWY STE 106 ROSWELL GA 30076

Insider Roles

Name	Transaction Date	Position
VistaGen Therapeutics Inc	2011-05-11	director
Durect Corp	2003-09-22	director
SciClone Pharmaceuticals Inc	2017-10-13	director
PDL BioPharma Inc	2008-04-09	director
InSite Vision Inc	2007-12-10	director
Incyte Corp	2004-03-30	director

EMBED

SAVE

SAXE JON S trading performance

Average Relative Return

137.44%

Average relative return per transaction

Outperforming Transactions

90%

9 out of 10 outperforming transactions.

Each transaction is measured over a period and compared to .

SAXE JON S trading performance analysis

	1 Month	3 Months	6 Months	1 Year	2 Years	3 Years
Relative Return(%)	-0.43	52.93	108.49	137.44	39.66	114.5
Relative Return to S&P 500(%)	-2.86	49.82	99.88	132.37	-1.63	75.49

Saxe Jon S trading transactions

Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
Ticker	Company	Current Price	Insider Name	Insider Position	Date	Buy/Sell	Insider Trading Shares	Shares Change	Price	Cost	Final Share	Price Change Since Insider Trade (%)	Filing Date	Dividend Yield %	PE Ratio	Market Cap ($M)
VTGN	VistaGen Therapeutics Inc	$1.03	SAXE JON S	Director	2020-08-21	Buy	30,000	129.03%	$0.69	$20,700	53,251	50%	-	0	At Loss	214.79
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2019-06-10	Buy	25,000	16.36%	$0.55	$13,750	177,810	-27.27%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2019-05-24	Buy	30,000	24.43%	$0.63	$18,900	152,810	-36.51%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2019-05-13	Buy	40,400	89.78%	$0.70	$28,280	85,400	-42.86%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2019-05-13	Buy	9,600	8.48%	$0.71	$6,816	122,810	-43.66%	-	0	At Loss	89.80
VTGN	VistaGen Therapeutics Inc	$1.03	SAXE JON S	Director	2019-03-14	Buy	20,000	615.20%	$1.26	$25,200	23,251	-17.86%	-	0	At Loss	214.79
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2019-03-13	Buy	3,700	5.35%	$0.82	$3,034	72,810	-51.22%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2019-03-13	Buy	21,300	106.50%	$0.82	$17,466	41,300	-51.22%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2012-12-12	Buy	15,000	45.72%	$0.91	$13,650	47,810	-56.04%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2012-08-28	Buy	7,810	31.24%	$0.97	$7,575.70	32,810	-58.76%	-	0	At Loss	89.80
DRRX	Durect Corp	$0.40	SAXE JON S	Director	2012-08-23	Buy	5,000	25%	$1	$5,000	25,000	-60%	-	0	At Loss	89.80
SCLN	SciClone Pharmaceuticals Inc	$11.15	SAXE JON S	Director	2007-11-21	Buy	15,000	100%	$1.90	$28,500	15,000	486.84%	-	0	At Loss	581.94
INSV	InSite Vision Inc	$0.35	SAXE JON S	Director	2007-09-13	Buy	15,000	68.18%	$1.09	$16,350	37,000	-68.12%	-	0	At Loss	45.34
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-04-18	Sell	5,000	-74.85%	$30.01	$150,050	1,680	-91.77%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-04-10	Sell	5,000	-42.81%	$30.58	$152,900	6,680	-91.92%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-04-03	Sell	10,000	-46.13%	$32.78	$327,800	11,680	-92.46%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-29	Sell	5,000	-18.74%	$32	$160,000	21,680	-92.28%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-27	Sell	5,000	-15.78%	$31.25	$156,250	26,680	-92.10%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-20	Sell	10,000	-23.99%	$32.24	$322,400	31,680	-92.34%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-13	Sell	10,000	-19.35%	$31.72	$317,200	41,680	-92.21%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-08	Sell	5,000	-8.82%	$32.12	$160,600	51,680	-92.31%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-06	Sell	5,000	-8.11%	$31.37	$156,850	56,680	-92.13%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-03-03	Sell	5,000	-7.50%	$32	$160,000	61,680	-92.28%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-02-27	Sell	5,000	-6.98%	$30.71	$153,550	66,680	-91.96%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-02-24	Sell	5,000	-6.52%	$30	$150,000	71,680	-91.77%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-01-09	Sell	6,000	-7.26%	$30.69	$184,140	76,680	-91.95%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-01-05	Sell	5,000	-5.70%	$30	$150,000	82,680	-91.77%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2006-01-04	Sell	5,000	-5.39%	$30.03	$150,150	87,680	-91.77%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2005-12-23	Sell	10,000	-9.74%	$30	$300,000	92,680	-91.77%	-	0	At Loss	282.14
PDLI	PDL BioPharma Inc	$2.47	SAXE JON S	Director	2005-10-04	Sell	5,000	-4.64%	$30.27	$151,350	102,680	-91.84%	-	0	At Loss	282.14

Total 30

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

SAXE JON S personal network

Name	Position	Linked company

Get Premium to unlock powerful stock data

Product

Business

Information

About

Affiliate Program

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Earn affiliate commissions by embedding GuruFocus Charts

GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.